Natural Health Products Program Advisory Committee Agenda: Meeting #4, March 22 and 23, 2010

Agenda

Place

Ottawa

Date

March 22 and 23, 2010

Participants

Members

• Ms. Anuradha Bose, Options consommateurs (Day 1)
• Ms. Carole Bouchard, National Association of Pharmacy Regulatory Authorities (Alternate)
• Ms. Paula Brown, British Columbia Institute of Technology
• Mr. Carl Carter, Canadian Health Food Association
• Mr. Joseph Chan, Bayer Inc., Consumer Care
• Mr. Lawrence Cheng, Chamber of Chinese Herbal Medicine of Canada
• Ms. Suzanne Gaudette, Canadian Homeopathic Pharmaceuticals Association
• Ms. Barbra J Johnston, Nature’s Formulae Health Products Inc.
• Mr. Gary Leong, Jamieson Laboratories Inc.
• Ms. Shawn O’Reilly, Canadian Association of Naturopathic Doctors
• Mr. Ron Rosenes, Canadian Treatment Action Council
• Mr. David Skinner, Consumer Health Products Canada
• Mr. Ron Smith, Natural Factors Nutritional Products Inc.
• Ms. Leah Stephenson, Best Medicines Coalition (Alternate)

Health Canada

• Ms. Michelle Boudreau, Director General, Natural Health Products Directorate (NHPD)
• Ms. Diana Dowthwaite, Director General, Health Products and Food Branch Inspectorate (HPFBI)
• Ms. Lara Boulanger-Stewart, NHPD
• Mr. Matthew Bown, HPFBI
• Mr. Don Boyer, Director, NHPD
• Ms. Lucie Desforges, HPFB Office of Consumer Affairs and Public Involvement (observer, Day 1)
• Ms. Diane Henry, NHPD
• Dr. Alison Ingham, NHPD
• Ms. Andrea McKenzie, NHPD
• Ms. Nancy Richards, Senior Executive Director, NHPD
• Ms. Carol Toone, NHPD
• Ms. Christine Zaczynski, HPFBI

Day One: March 22, 2010

Item #1

Welcome,  Introductions and General NHP-PAC Governance
Ms. Nancy Richards, Senior Executive Director, NHPD

Item #2

Management of Natural Health Products Licence Applications: Presentation by the NHPD
Mr. Don Boyer, NHPD

Item #3

Working Group #3 – Compliance and Enforcement Related to Natural Health Products (C&E):Discussion on Issues and Workplan
Ms. Suzanne Gaudette, Chair, Working Group #3 on C&E
Ms. Christine Zaczynski, HPFBI
Mr. Matthew Bown, HPFBI

Item #4

Report on Fungal Enzymes: Related to Report #1 on Standards of Evidence for Non-traditional Natural Health Products, Recommendation 29.
Mr. Don Boyer, NAPRA

Day Two: March 23, 2010

Item #5

Report #1 on Standards of Evidence for Non-traditional Natural Health Products: NHPD Response to the Committee on the recommendations presented in Report #1
Ms. Alison Ingham, NHPD

Item #6

Report #2 on Product Testing Requirements Connected to Good Manufacturing Practice Requirements for Natural Health Products: NHPD Response to the Committee on the recommendations presented in Report #2
Ms. Alison Ingham, NHPD

Item #7

Working Group #3 on Compliance & Enforcement (C&E) Related to NHPs: Presentation to the Committee
Ms. Suzanne Gaudette, Chair, Working Group #3 on C&E
Ms. Christine Zaczynski, HPFBI
Mr. Matthew Bown, HPFBI

Item #8

National Association of Pharmacy Regulatory Authorities: Update
Ms. Michelle Boudreau, NHPD

Item #9

Next meeting (tentative): July-14-15, 2010, Ottawa